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Background: Cochrane reviews are one of the best known and most trusted sources of evidence-based information in
health care. While steps have been taken to make Cochrane intervention reviews accessible to a diverse readership,
little is known about the accessibility of the newcomer to the Cochrane library: diagnostic test accuracy reviews
(DTARs). The current qualitative study explored how healthcare decision makers, who varied in their knowledge and
experience with test accuracy research and systematic reviews, read and made sense of DTARs.
Methods: A purposive sample of clinicians, researchers and policy makers (n = 21) took part in a series of think-aloud
interviews, using as interview material the first three DTARs published in the Cochrane library. Thematic qualitative
analysis of the transcripts was carried out to identify patterns in participants’ ‘reading’ and interpretation of the reviews
and the difficulties they encountered.
Results: Participants unfamiliar with the design and methodology of DTARs found the reviews largely inaccessible and
experienced a range of difficulties stemming mainly from the mismatch between background knowledge and level of
explanation provided in the text. Experience with systematic reviews of interventions did not guarantee better
understanding and, in some cases, led to confusion and misinterpretation. These difficulties were further exacerbated
by poor layout and presentation, which affected even those with relatively good knowledge of DTARs and had a
negative impact not only on their understanding of the reviews but also on their motivation to engage with the text.
Comparison between the readings of the three reviews showed that more accessible presentation, such as presenting
the results as natural frequencies, significantly increased participants’ understanding.
Conclusions: The study demonstrates that authors and editors should pay more attention to the presentation as well
as the content of Cochrane DTARs, especially if the reports are aimed at readers with various levels of background
knowledge and experience. It also raises the question as to the anticipated target audience of the reports and suggests
that different groups of healthcare decision-makers may require different modes of presentation.
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reproduction in any medium, provided the orhas been extended to making this information available
and accessible to a diverse group of decision makers,
such as healthcare practitioners, policy makers and con-
sumers. While significant efforts have been made to im-
prove the accessibility of the Cochrane systematic
reviews of interventions (hereafter referred to as
‘Cochrane intervention reviews’), very little is known
about the accessibility of the newcomer to the Cochrane
library - the diagnostic test accuracy reviews (DTARs).
DTARs are systematic reviews of diagnostic test accur-
acy studies - primary studies that assess the ability ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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target condition by measuring the test’s error rate. In
test accuracy studies, the results from the evaluated
diagnostic test (index test) are compared with those
from a reference standard - a diagnostic test or a com-
bination of tests considered to be the most reliable way
of diagnosing the target condition and assumed to be
100% accurate. The discrepancies in the results are used
to measure the diagnostic accuracy of the index test as
compared to the reference standard. The study may also
have a comparative design, in which case two or more
index tests are evaluated, hopefully against the same ref-
erence standard. A range of test accuracy statistics is de-
rived from the resultant contingency table, in order to
summarize and communicate different aspects of the
test’s ability to identify the target condition (Table 1).
The measures most commonly reported in the literature
are the test’s sensitivity and specificity, which represent
the proportions of correctly diagnosed diseased and
non-diseased patients, respectively. However, in some
cases other test accuracy measures, such as diagnostic
odds ratios, predictive values and likelihood ratios, may
be more relevant, depending on the type of decisions the
information will be used for [1].
Test accuracy information is used by policy makers,
practitioners and researchers in a wide range of
decision-making contexts such as:
 Making decisions about the introduction of new
diagnostic tests;
 Evaluation of the effectiveness and efficiency of
current diagnostic practices;
 Development of more effective and efficient
diagnostic strategies, and
 A range of clinical decisions such as whether the
test should be ordered and the probability of the
target condition in individual patients giving a
positive or a negative test result.
Like all other research, test accuracy evaluations are
prone to bias and their use in decision making requires,
as a preliminary step, a rigorous assessment of their val-
idity and applicability. It has been demonstrated that
such studies often suffer from serious methodological
shortcomings; their sample sizes are usually too small
to allow the calculation of precise estimates of testTable 1 Two-by-two table and derivative test accuracy measu
Reference standard
Disease present
Index test (test under evaluation) Positive result True positive (TP)
Negative result False negative (FN)
Test accuracy measures → Sensitivity = TP/(TP+Faccuracy; and they are poorly reported, which makes the
assessment of their methodological quality and applic-
ability difficult [2-7]. Also, a number of studies have
shown that both healthcare professionals and consumers
find test accuracy information confusing and struggle to
apply it correctly when interpreting the results from
diagnostic tests [8-26].
The application of systematic review methods to test
accuracy evaluations allows for a more comprehensive,
rigorous and transparent way of gathering, appraising
and analyzing the existing evidence and, in some cases,
enables the calculation of more accurate estimates by
pooling the results from several individual studies [27].
Although such methods hold the promise of producing
better quality information, they have their own limita-
tions, biases and complexities and conveying their re-
sults to a diverse audience is equally challenging.
Over the past few years, the Cochrane Collaboration has
been developing its methods for systematic reviews of test
accuracy studies, with the first review being published in
2008 and an increasing number of DTARs being published
since then. As for all Cochrane reviews, the expectation
within the Cochrane collaboration is that the Cochrane
DTARs should be accessible to a wide range of healthcare
decision makers across the world. At present, however,
very little is known about the difficulties that different
stakeholders in the healthcare system might experience
when reading and trying to make sense of a Cochrane
DTAR and, to our knowledge, no research has yet been
done in the accessibility of this type of review.
To start filling this gap, we conducted a qualitative study
investigating UK-based healthcare decision makers’ ex-
perience of reading, and making sense of, a Cochrane
DTAR. The current paper reports on the main findings
and discusses possible ways of making Cochrane DTARs
more accessible. It also raises the question about the target
readership of these documents and the need to use differ-
ent formats to convey the results from the Cochrane
DTARs. Although the focus of the study is specifically on
the accessibility of the Cochrane reviews, many of the
findings are relevant to and could be applied to improve
the accessibility of DTAR reports in general, and to other
types of systematic reviews.
This project was funded by a NIHR Cochrane - NHS
Engagement Award. Visit the NETSCC website for more
details (http://www.netscc.ac.uk/). The views and opinionsres
(disease status) Test accuracy measures ↓
Disease absent
False positive (FP) Positive predictive value = TP/(TP+FP)
True negative (TN) Negative predictive value= TN/(TN+FN)
N) Specificity = TN/(TN+FP) Diagnostic odds ratio = (TPxTN)/(FPxFN)
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cessarily reflect those of the Department of Health. The
study received an ethical approval from the local NHS re-
search ethics committee.
Methods
In order to explore the processes through which
healthcare professionals make sense of a DTAR and the
difficulties, if any, they encounter with different aspects
of the review, we conducted a series of interviews based
on the think-aloud interviewing technique. The think-
aloud interview is a method widely used in psychological
and social research when an understanding of the cogni-
tive processes involved in the completion of a specific
task, such as reading and making sense of a text, is
sought [28-31]. It consists of asking participants to
verbalize their thoughts while working on the task, thus
making ‘visible’ the cognitive aspects of the problem-
solving process. The interview is recorded and tran-
scribed verbatim and, depending on the objectives of the
study, a variety of methods for analysis have been pro-
posed [28-35]. Although, this technique has gained sig-
nificant popularity in the study of text comprehension,
its application in studying the understanding of intact,
naturally- occurring texts, especially complex and volu-
minous texts such as systematic reviews, has been lim-
ited [28]. For the purposes of the current study we
adapted the method so that we could capture not only
participants’ verbalizations but also their non-verbal
interaction with the text. We assumed that participants’
understanding of the reviews would depend on a range
of factors that could be grouped into the following three
categories: background knowledge and experience, char-
acteristics of the text and characteristics of the task.
Keeping the task constant, we explored the interaction
between background knowledge and text presentation
using three different reviews and interviewing a purpos-
ive sample of healthcare decision-makers with diverse
background knowledge.
As interview material, we used the following Cochrane
DTARs:
 ‘Galactomannan detection for invasive aspergillosis
in immunocompromized patients’ [36].
 ‘Magnetic resonance imaging versus computed
tomography for detection of acute vascular lesions
in patients presenting with stroke symptoms’ [37].
 ‘Physical examination for lumbar radiculopathy due to
disc herniation in patients with low back pain’ [38].
For shortness, we will refer to them here as the
Galactomannan review, the MRI versus CT review and
the Physical examination review, respectively. We chose
these particular reviews because at the time of conductingthe study they were the only full text DTARs published in
the Cochrane library. Further details of the reviews are
provided in Table 2.
Participants and sampling
Participants’ selection was based on the results from an
online survey reported here as an additional file [see
Additional file 1]. We used the survey to gather prelim-
inary information about prospective participants’ famil-
iarity with diagnostic test accuracy (DTA) concepts and
methods, systematic review methodology and the three
DTARs chosen as interview material. Prospective partici-
pants in the survey were clinicians to whom the subject
areas of the reviews were of relevance, and policy makers
and researchers involved in decision making about diag-
nostic tests. We decided to exclude consumers and
carers, not because we believe that this type of review is
not relevant to them, but because at present the
Cochrane DTARs contain no Plain language summary,
which already suggests that in their current format the
reviews are not intended for non-specialist audience. We
acknowledge, however, that diagnostic accuracy is rele-
vant to everybody who makes decisions about diagnostic
tests, including consumers and carers, and that, ultim-
ately, the results of the Cochrane DTARs should be
made accessible to all of them, even though this may re-
quire different formats and presentations.
Prospective participants were contacted via profes-
sional organizations and networks and, after completing
the survey, were asked whether they would like to take
part in an interview. To ensure we understood a range
of perspectives, we purposively sampled people with
high or low levels of experience in four key spheres: the
clinical area, DTARs, systematic review methods gener-
ally and policy making. The volunteers selected for
interviewing were allocated to one of the three reviews,
with the clinicians being allocated to the reviews rele-
vant to their specialty and the participants with non-
clinical backgrounds allocated so as to balance the three
groups in terms of participants’ clinical and methodo-
logical knowledge (Table 3).
Interview procedure
At the beginning of the interview, participants were
helped to practice the think-aloud technique on a sample
of informational text [28-30]. The instructions for the
main task were as follows. Participants were asked to im-
agine that they were members of a policy making commit-
tee which was considering the application of the evaluated
tests. They had been asked to read the selected review and
to feed back to the committee the points they considered
most important, with the supporting evidence. This sce-
nario was chosen because it was relevant to a wide range
of healthcare professionals including policy makers,
Table 2 Details of the three DTARs used as interview material
Galactomannan review MRI versus CT review Physical examination review
Index test(s) Galactomannan sandwich ELISA
(Platelia©)
Diffusion-weighted MRI and CT (for the diagnosis
of acute ischemic stroke); MRI (for the diagnosis of
acute hemorrhagic stroke)
A number of physical examination
tests such as straight leg raising and
crossed straight leg raising tests.
Reference
standard
EORTC/MSG criteria (see review) Acute ischemic stroke: a combination of clinical
and imaging information supported by clinical or
imaging follow-up (CT or MRI) or autopsy;
Diagnostic imaging or findings at
surgery
Acute hemorrhagic stroke: a clinical diagnosis
supported by CT or autopsy
Target condition Invasive aspergillosis Acute ischemic stroke; acute hemorrhagic stroke Radiculopathy due to lower
lumbar disc herniation
Presentation of
the results from
meta-analysis
Estimates of sensitivity and specificity
(percentages) and false positive and false
negative rates (natural frequencies)
Estimates of sensitivity and specificity
(percentages)
Estimates of sensitivity and
specificity (percentages)
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apply the review results to a clinical scenario as this would
have required additional information, such as information
concerning patient outcomes, which was not available in
the reviews. Participants were instructed to think aloudTable 3 Participants background and experience
Review Professional
background (code
used in the quotes)
Kno
o
clin
Galactomannan detection for
invasive aspergillosis in
immune-compromized patients
Hematologist (H1)
Hematologist (H2)
Policy maker (PM1)
Systematic reviewer (SR1)
Health economist (HE1)
Systematic reviewer (SR2)
Physical examination for lumbar
radiculopathy due to disc herniation in
patients with low back pain
GP (GP1)
GP (GP2)
Physiotherapist (PH1)
GP (GP3)
Physiotherapist (PH2)
Policy maker (PM2)
Policy maker (PM3)
MRI versus CT for detection of acute
vascular lesions in patients presenting
with stroke symptoms
Radiologist (R1)
Systematic reviewer (SR3)
Health economist (HE2)
Health economist (HE3)
Systematic reviewer (SR4)
Systematic reviewer (SR5)
Systematic reviewer (SR6)
Policy maker (PM4)
Legend: DTA-related knowledge and systematic review methods: ‘Little’ - the partic
specificity/little understanding of systematic review methods; ‘Some’ - good unders
‘Good’ - familiar with DTA theory/systematic review methods.while reading the review specifically, to tell the researcher
what they were getting from the text, what they were
doing and any other thoughts that came to mind. We did
not place any restrictions on the participants’ verba-
lizations and encouraged them to verbalize everything thatwledge
f the
ical area
DTA-
related
knowledge
Systematic
review
methods
Academic
role within
university
Policy-
making
experience
Yes Good Some Yes Yes
Yes Good Some Yes Yes
No Some Good Yes Yes
No Little Good Yes No
No Little Good No No
No Good Good Yes Yes
Yes Little Little No No
Yes Little Little No No
Yes Little Good Yes No
Yes Good Good No Yes
Yes Good Good Yes Yes
Yes Good Good Yes Yes
No Some Good Yes Yes
Yes Little Little No No
No Little Some No No
No Good Good No Yes
No Little Some No No
No Little Good Yes No
No Good Good Yes No
Yes Some Good Yes No
Yes Good Good Yes Yes
ipant has poor understanding of basic DTA concepts such as sensitivity and
tanding of basic DTA concepts/general idea of systematic review methods;
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clear to them, however, that we were interested in their
thoughts emerging in relation to the task they were
performing rather than in general comments or explana-
tions. Participants were also told that there was no set
time within which they had to complete the think-aloud
task. They were asked, however, to allow an extra 15 mi-
nutes for additional questions and for closing the inter-
view. The interviews were video-recorded with the digital
camera set in such a way as to capture the page(s) being
referred to and the participants’ actions with the text, such
as leafing through the pages, highlighting, pointing to spe-
cific passages and so on. The video recording allowed eas-
ier synchronization of the verbal protocol with the parts
of the document being used and better documentation of
the non-verbal behaviour, which would have been difficult
if only audio recording was used.
Participants received a full single-sided color-printed
copy of the review they were allocated and a pen,
highlighters and paper. They were told that if they wished,
they could take notes or write directly on the document.
At the end of the interview, the review and the partici-
pants’ notes were collected to be used in the analysis.
Once the think-aloud part of the interview was com-
pleted, participants were asked to interpret specific ele-
ments of the review such as the Methodological Quality
Graphs, the forest plot and/or the SROC plot, if they
had not done so during the interview. Participants were
also asked a number of questions clarifying:
 Their experience with diagnostic test accuracy
information, especially in terms of using such
information in their everyday practice;
 Their experience with DTARs and other types of
systematic reviews; and,
 Their knowledge of the subject area including
experience with the evaluated tests.
Interview records were transcribed verbatim and seg-
mented into sections that followed the structure of the
review, such as ‘abstract’, ‘background’ and so on. The
segmented transcripts, together with the video records,
were imported into NVivo (a qualitative research soft-
ware; NVivo v.8, QSR International) and synchronized.
Each interview was watched section by section and a de-
scription of any significant non-verbal behaviour was
added to the transcript. Inductive coding - coding based
on the themes emerging from the data [39] - was carried
out, focusing on three broad categories of events:
 Participants’ interaction with the text, such as the
sequence and manner of reading, read/ignored text
or diagrams, non-verbal expressions of hesitation,
confusion and so on; Interpretation of information; and,
 Errors, difficulties and problems.Analysis
The interviews were then analyzed by comparing partici-
pants’ behavior, interpretations and the difficulties they ex-
perienced at each section of the document, within and
across the three reviews, and between different categories
of participants. The whole process was highly iterative, in-
volving repeated watching of the interviews, or segments
of them, and going back and forth between different
stages. In order to ensure that participants’ verbalizations
were interpreted correctly, two researchers watched and
analyzed a sample of the interviews. Specific examples, es-
pecially those related to errors and difficulties, were
discussed at regular team meetings and with members of
the steering group, who are specialists in DTAR
methodology.Results
We estimated that the invitation was sent to more than
1,200 healthcare professionals, of whom only 103 com-
pleted the survey (< 10% response rate) and only 46
volunteered to take part in an interview (< 5%), with some
of them subsequently pulling out due to busy schedules or
other reasons. The volunteers tended to have greater
knowledge of test accuracy and systematic review methods
and to be involved in teaching or research (see Additional
file 1). We selected interview participants aiming to
achieve maximum variability in terms of background
knowledge and experience with the subject area, system-
atic review methods, DTA concepts and methods and use
of research evidence in policy making. We stopped
conducting more interviews when new themes stopped
emerging and sufficient data was available on the ones
already identified. Eight of the included participants were
clinicians and 13 had non-clinical background. In terms of
specialty, we interviewed one radiologist, two hematolo-
gists, three general practitioners and two physiotherapists.
Of the non-clinicians, six were systematic reviewers, three
were health economists and four were members of local
and/or national policy making bodies (see Table 3). The
interviews took place in venues chosen by the participants,
usually their offices, and took between 30 minutes and
one hour to complete the ‘think aloud’ task with the whole
interview taking between one and one and a half hours.
Below we present the interview results by looking at
how different categories of participants read the reports,
the range of difficulties they experienced and the impact
that difficulties, reading strategies and presentation of
information in the reports had on their overall under-
standing of the reviews. Individual participants are iden-
tified throughout the text by unique codes that can be
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in Table 3.
Reading patterns
The abstract was used as a ‘gateway’ to the review - par-
ticipants read it first in order to ascertain the relevance
of the review and its potential to inform clinical and pol-
icy decisions. The reading of the reviews was highly se-
lective, with the employed reading strategies reflecting
participants’ perceptions of accessibility, relevance and
importance. Differences were observed between those
who were familiar with the methodology of systematic
reviews (PM1, SR1, HE1, SR2, PH1, GP3, PH2, PM2,
PM3, HE2, SR4, SR5, SR6, PM4) and those who had lit-
tle experience with this type of research (GP1, GP2, R1).
The former group of participants knew broadly what to
expect in the report, they were more strategic when
choosing what and how to read and their reading was
more iterative, resembling the process of putting to-
gether a jigsaw puzzle: they prioritized their reading and
looked for information they considered relevant and im-
portant, such as inclusion and exclusion criteria, refer-
ence standard and methodological quality assessment;
and tended to ignore those aspects of the review they
knew were standard for all Cochrane reviews, such as
data extraction and management procedures. They tried
to make sense of the review by piecing together different
bits of information and identifying missing elements, and
comparing the emerging picture with their understanding
of a well-conducted systematic review. In some cases, a
lack of familiarity with methods specific to DTAR ham-
pered participants’ understanding and led to misinterpre-
tations and wrong conclusions, which will be discussed in
the next section (PM1, SR1, HE1, PH1, SR4, SR6).
Participants who had limited understanding of system-
atic review methods - all of whom were non-academic
clinicians (GP1, GP2, R1) in our sample - adopted a dif-
ferent strategy. After reading the abstract they stated
that, in the real world, they would not read the rest of
the review, since they were interested mainly in the re-
sults, considered the methodological aspects irrelevant
or difficult to understand, and had limited time to read
such papers. They read the reviews in a linear manner,
starting from the beginning and reading through to the
end, skimming over and skipping parts of the text they
considered inaccessible or irrelevant for them as clini-
cians. They focused on sections that provided an access-
ible narrative summary of the results, such as the
abstract and the conclusions section and consistently
skipped the methods and results sections, which they
found particularly difficult and/or considered irrelevant
to the clinician’s role.
Participants’ understanding of the abstract strongly
influenced their decisions on whether and how to readthe rest of the review; and had an impact on their fur-
ther interpretations of the text. In some cases, misunder-
standing of information provided in the abstract
remained unchecked due to participants skipping sec-
tions of the review and often resulted in further confu-
sion and misinterpretations. This is considered in more
detail below.
Difficulties experienced when reading the DTAR
We grouped the difficulties experienced by participants
in the following categories, those related to:
 The design of DTARs;
 The interpretation of results when presented as
sensitivity and specificity;
 The review methods specific to DTARs; and,
 Poor layout and presentation of information in the
reports.
Difficulties related to the design of DTARs
Half of the participants in the study had limited experi-
ence with diagnostic research and, as a result, poor under-
standing of its design. On the other hand, practically all
participants had some experience with intervention re-
views and, drawing on this knowledge, made assumptions
about the design of DTARs which, in some cases, were
wrong, and led to misunderstanding and confusion.
The most common error was to misinterpret the role
of the reference standard as if it was a comparator. A
number of participants (GP1, GP2, R1, HE3) acknowl-
edged that they did not know the meaning of the terms
‘index test’ and ‘reference standard’ as used in the con-
text of diagnostic accuracy research. As a result, they
mistakenly assumed that the index test was compared to
the reference standard in order to establish which of the
two technologies was performing better. A related
source of confusion was the wrong assumption that
DTARs are comparative in nature, probably as a result
of participants’ greater experience with comparative inter-
vention reviews. Two factors in the presentation of the re-
views contributed to the above problems. First, no glossary
of key terminology was provided in the text and even when
participants felt uncertain about the meaning of specific
terms, they were unable to find a definition. Second, when
the roles of the tests were not clearly and explicitly defined
in the abstract, participants made assumptions, which were
sometimes wrong and affected their understanding of
the subsequent sections. Wrong interpretations often
remained unchecked as a result of the participants skipping
the methods and results sections of the review - and led to
a misunderstanding of the final results.
For example, in the Physical examination review the
diagnostic accuracy of different physical tests and their
combinations was assessed for the diagnosis of disc
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read: ‘When used in isolation, current evidence indicates
poor diagnostic performance of most physical tests used
to identify lumbar disc herniation. However, most find-
ings arise from surgical populations and may not apply
to primary care or non-selected populations. Better per-
formance may be obtained when tests are combined’.
(van der Windt et al. 2010, p2).
The roles of the different tests, however, were not ex-
plicitly defined in the abstract. One of the participants
who read this review (PH1) - a clinician with some ex-
perience with intervention reviews but none with
DTARs - after reading the abstract, wrongly assumed
that the statement ‘Better performance may be obtained
when tests are combined’ (van der Windt et al. 2010,
p2) referred to a combination of physical tests (index
test) and imaging (reference standard):
‘So what this is saying to me overall is that the sort of
physical tests that you would use aren’t particularly
good at actually diagnosing this disc herniation, but
when they’re using imaging … err … tests in
combination with it, the tests are slightly more
accurate, but still not great.’ (PH1)
Since she skipped most of the methods and results
sections, she remained under this impression until the
very end of the reading and it was reflected in her final
message. In this case, the lack of experience with diag-
nostic research, and the fact that the roles of the tests
were not explicitly defined in the abstract, interacted
with the participant’s reading strategy to result in a
complete misunderstanding of the review.
This problem was encountered more frequently in
participants reading the MRI versus CT review, which
combined two different evaluations - comparative and
non-comparative - with the computed tomography (CT)
being an index test in the first evaluation and part of the
reference standard in the second. This complexity, how-
ever, was not made prominent enough in the abstract
and other sections of the review - in terms of wording
and layout - and even participants with good knowledge
of DTAR methods got the roles of the tests wrong at
first and only after reading the whole review understood
what was compared and why. One such participant, who
initially misunderstood the design of the review, after
reading the full text, commented:
‘The abstract was fairly vague. When reading the
abstract, I thought they were comparing MRI - well,
MRI with CT for acute stroke. I suppose when you are
looking back at it, it makes more sense … but not
straight away … I wasn’t clear what they were doing. It
wasn’t clear what the reference standard was. It lookedlike the CT was the reference standard rather than
imaging with clinical follow-up or autopsy.’ (SR5)
Participants less familiar with DTAR methods found
this lack of clarity even more confusing and some of
them failed to understand the design of the review even
after reading the full text (R1, SR3, HE3).
Difficulties interpreting the results when presented as
sensitivity and specificity
Participants unfamiliar with DTA research struggled to
make sense of the review results when presented as sen-
sitivity and specificity and experienced the following
difficulties:
 They could not recall the definitions for sensitivity
and specificity and spontaneously commented that,
since they did not come across these terms very
often, they always found them confusing and every
time had to look them up:‘And then what I am also learning is that OK, it is
quite specific, and I always get specificity and
sensitivity mixed up, probably because I don’t teach it,
and I always have to go back and look it up, but I
think ‘specific’ means that if it is there, it will
demonstrate it but it is also not particularly sensitive
and has a high false negative. I don’t know if that is
right or not, but there we are.’ (GP1)
Limited use of test accuracy information in clinical prac-
tice was reported by most of the clinicians who took part
in the study, which seems to explain the observation that
non-academic clinicians (R1, GP1, GP2) found DTA infor-
mation more difficult to interpret when compared to their
colleagues involved in teaching (H1, H2, PH2).
 Participants confused sensitivity (the proportion of
test-positive among those with the disease) and
specificity (the proportion of test-negative among
those without the disease) with the positive and
negative predictive values (the proportion of
diseased among those with a positive test result and
non-diseased among those with negative test result,
respectively).‘So more sensitive … more sensitive tests would mean
that … would find out more positive … if they’re …
yeah … I’m rubbish at this, so I have to write a little
table (draws 2×2 table). So if you’ve got a true positive,
if you’ve got lots of true positives, even if you get a few
false positives that’s sensitivity. And if you have a high
specificity means that the positives you do have are
really all proper positives and you haven’t got many …
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Aaah, I don’t know (laughing nervously).’ (R1)
In the above excerpt, the participant wrongly assumed
that sensitivity refers to the proportion of true positives
among those with positive test results (which is the posi-
tive predictive value), while in fact it refers to the propor-
tion of true positives among those who have the disease.
 Participants misinterpreted sensitivity and specificity
estimates by wrongly applying heuristics that they
had learnt in relation to ratio measures. More
specifically, when interpreting the confidence
intervals of sensitivity and specificity, participants
looked to see whether or not the confidence interval
was crossing one. In the context of ratio measures, if
the confidence interval crosses one this would mean
that the difference between the compared
interventions could be due to a chance and,
therefore, is not statistically significant. Participants
mistakenly transferred this rule when interpreting
the confidence intervals of sensitivity and specificity
and wrongly concluded that a confidence interval
reaching 1.00 (100% sensitivity or specificity)
indicated poor test performance. This type of
misinterpretation was encountered both when
participants interpreted the summary estimates and
when interpreted the forest plots, as illustrated in
the following excerpt:‘Now I am racking my brain to try and remember
how to interpret these (forest plots), which I should
be able to, and my brain says that if it crosses 1 … or
0 … it is not relevant. I can’t remember. I will wait till
I am told. So there is a lot of heterogeneity (reading
the text) so … OK, I am slightly confused at this
stage!’ (GP2)
This type of error was encountered only in non-
academic clinicians who had little experience with both
intervention reviews and DTARs (GP1, GP2, R1).
 Some participants tried to infer as to whether the
evaluated tests would be useful as rule-in or rule-out
tests (H1, H2, SR2, GP1, GP3, PH2, PM2, R1, HE2,
SR5, PM4). In principle, a rule-in test needs to be
very specific so that the rate of false positives is low
and a positive test result is more likely to be a true
positive; a rule-out test, on the other hand, needs to
be very sensitive so that the rate of false negatives is
low and a negative test result is more likely to be a
true negative. Since this is counterintuitive, some
participants (R1, GP1, GP3) got confused and
wrongly dismissed tests that had lower sensitivity asuseless for ruling in the condition, even when they
were very specific and, therefore, perfect for this
role. Such mistake was made even by a participant
(GP3) who had in the past been involved in
diagnostic accuracy research. In this case, the
misinterpretation was due to ‘rusty’ knowledge
rather than to a lack of understanding. It shows,
however, that such mistakes are easy to make,
especially when the knowledge is not routinely used
in everyday practice.
 Another, more general issue, reflecting participants’
statistical literacy rather than their knowledge of
DTAR methods, was their tendency to ignore the
confidence intervals when interpreting the summary
estimates for sensitivity and specificity. By doing so,
some participants (R1, SR3, HE3) came to the
wrong conclusion that one of the compared tests
was better than the other while, in fact, the wide
and overlapping confidence intervals suggested that
there was a significant level of uncertainty and no
definite conclusions could be drawn from the
results. This problem was exacerbated when the
statistical uncertainty was not explicitly discussed in
the authors’ interpretations of the results.
Presenting the results as positive and negative error
rates expressed as natural frequencies (Galactomannan
review) greatly improved participants’ understanding:
‘Err, the overall sensitivity 78%, specificity 81%. Err …
okay, so sensitivity picks up how many … err…I always
get muddled up between the difference between
sensitivity and specificity (laughs). Okay … Okay,
conclusions - a cut-off value 0.5. Yeah. That’s what the
consequences would be. You would have … two
patients missed if you had 8% prevalence, 17 patients
will be treated unnecessarily. Okay. If you use a cut-off
of 1.5, you would miss three, treat wrongly five. Okay.
But the results were very heterogeneous.’ (HE1)
The above quote shows that even participants with
limited understanding and experience with test accuracy,
who initially struggled to make sense of the information
when presented as sensitivity and specificity, immedi-
ately grasped the implications of the results when the
same information was presented as natural frequencies.
Such presentation was found useful even by participants
with relatively good understanding of DTAR methods, as
illustrated by the following excerpt:
‘And they have actually concluded that if you have a
low level, 0.5 (cut off ), a disease prevalence of 8%, two
patients will be missed, that’s 2% presumably, of 100
patients. Seventeen patients will be treated
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mean three patients will be missed and five will
receive unnecessary treatment. And that’s actually
quite a useful way of actually presenting the data
relating to sensitivity and false positives, false
negatives.’ (H1)
This form of presentation was welcomed by everybody
who read the Galactomannan review and was suggested
as a good way of communicating the results to a non-
expert audience.
Difficulties related to a lack of familiarity with review
methods specific to DTARs
Participants who had limited experience with DTARs
and little knowledge of the methods specific to this type
of review experienced a number of difficulties when
reading the methods section and trying to make sense of
the results.
Study design Participants who had limited experience
with diagnostic accuracy research (those with ‘little’ or
‘some’ DTA-related knowledge in Table 2) were not fa-
miliar with different types of study design used in diag-
nostic research and did not know what the implications
of including or excluding specific designs were:
‘What I’m thinking now is ‘Are they the sort of studies
that I would think would be best for a diagnostic test?
I don’t look at diagnostic tests often, so I don’t know.
I’m used to looking at treatments, so I’d normally
want to see randomized controlled trials. Case control
study? Sounds OK. Cross-sectional studies. But I’d
probably want to do a little extra reading around; is
this the type of thing that’s usually looked at for
diagnostic tests?’ (PM1)
Methodological quality assessment With a few excep-
tions (SR2, PM2, HE2, SR5), most of the participants were
unfamiliar with the Quality Assessment tool for Diagnostic
Accuracy Studies (QUADAS) and, as a result, struggled to
make sense of the assessment [40-42]. The definitions of
the individual assessment criteria provided in the reviews
focused on the way in which the QUADAS items had been
customized for the purpose of the particular review and as-
sumed prior knowledge of the original QUADAS criteria.
Participants unfamiliar with QUADAS found these defini-
tions largely inaccessible and tended to skip them:
(Participant): ‘I’m just looking at these headings (of
the methodological criteria), I’ve got no idea what
they’re going to include under those paragraphs
headings (browsing over the text without reading
through).’(Researcher): ‘Can you pick one and try to see when
you read it through whether it makes sense?’(Participant): ‘Okay, let’s go for partial verification
prevented (reading) … No, that’s saying nothing to me
at all. Let’s try differential verification avoided
(reading)… No …’(Researcher): ‘So does it get clear when you read it
(the definition)?’(Participant): ‘No … It’s not … err … it’s not explained
to me clearly. I guess because it’s a … specialist thing
- you’ve got a specialist condition, specialist test, and
diagnostics is not something that we routinely have to
think about, and therefore I really need something
written aimed at a much, much lower level, because
this is just too technical.’ (PM1 reading the
Galactomannan review)
Having failed to make sense of the provided definitions,
participants tended to ignore the unfamiliar methodological
criteria, such as those related to verification and incorpor-
ation biases, and instead focused on items they were famil-
iar with, such as blinding. The definitions were presented
differently in the three reviews. In the Galactomannan re-
view a list of detailed definitions was provided within the
methods section; in the MRI versus CT review only brief
explanations of some of the criteria were given in the text,
without visually separating them from the rest of the para-
graph; and in the Physical examination review the list of
criteria was given in an appendix. Most successful in
‘attracting’ participants’ attention was the list of criteria pro-
vided in the Galactomannan review and least successful
was the appendix in the Physical examination review.
Participants’ approach to the methodological quality as-
sessment depended on their experience with systematic re-
views, as well as on their knowledge of the specific
QUADAS criteria. Those with little experience tended to
skip the section or to make very general comments often
driven by the color coding of the methodological quality dia-
gram. For instance, they made comments such as ‘lots of
red’ or ‘lots of green’, without understanding what the impli-
cations of not meeting a particular criterion were. The ‘traffic
light’ color coding was sometimes interpreted subjectively,
with participants focusing on the ‘red’ (poor quality) and
‘green’ (good quality) and ignoring the items coded ‘yellow’:
‘Basically what I would do if I was going to look at it,
I would look for the red dots and see what they
missed, and see how many greens there were.’ (PH2)
Also, the lack of key to the diagram in the Physical
examination review led to some participants interpreting
1-specificity
0.50
0.5
Figure 1 An example of a Summary Receiver Operating
Characteristics (SROC) plot of sensitivity versus 1-specificity.
Each rectangle represents the results from a single study; the width
and the height of the rectangles could be used to represent the
number of patients with and without the target condition; the solid
line is the summary ROC curve; the thick black spot is the mean
value for sensitivity and specificity; the ellipse around the black spot
represents the 95% confidence intervals around the
summary estimate.
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(its correct meaning) and combining the items coded
‘yellow’ and ‘green’ into ‘better quality studies’ category.
Other presentation issues also impacted on participants’
understanding of this section of the review. For instance,
all participants focused on the diagram and skipped the
associated text, which was placed on the following page.
They considered the text redundant while, in fact, it
contained important details about the performance on
specific criteria, which the participants missed.
Statistical analysis and data synthesis Only partici-
pants with expert levels of knowledge were familiar with
the statistical methods employed in the review, and only
they read in full the ‘Statistical analysis and data synthe-
sis’ section. The rest of the participants either completely
skipped or skimmed over this section expressing famil-
iarity with the 2×2 table, the forest plots and, in some
cases, with the ROC plot and stating that they lacked
the necessary expertise to discuss the appropriateness of
the statistical methods.
When reading the findings section of the review, partici-
pants who had poor understanding of basic DTA concepts
such as sensitivity and specificity struggled to interpret the
forest plots or misinterpreted the presented information
(GP1, GP2, SR3, SR4, HE3). For instance, participants who
misread the confidence intervals of sensitivity and specifi-
city estimates as if they were estimates of ratio measures,
made the same mistake when interpreting the forest plots
and either got confused and gave up, or misinterpreted
the information (R1, GP1, GP2, SR3, SR4).
Participants with limited DTA knowledge skipped the
SROC plot (Figure 1) either because they were unfamil-
iar with this type of diagram or because they were con-
vinced that it was extremely difficult to interpret. A lack
of detailed legend contributed to this decision and sig-
nificantly hindered the interpretation.
‘I mean, from that, there’s no key to tell me what all these
different boxes mean on this particular diagram. So it
doesn’t … I presume these are different studies, but
there’s nothing to tell me what anything means on this …
on this particular diagram. Err … so if I was to guess,
these are different … individual studies looking at the
sensitivity and specificity, and the size of box, I guess, is
to do with the sample size. I don’t know what the black
dot means, or this circle in the middle, the highlighted
bit. So for me, I would … because I’ve never seen this
diagram before, what I would do is look at the text in
terms of this. But whether this tells me any more (turning
page) than the previous forest plots, I don’t know.’ (PH1)
Even participants who had come across an ROC plot
before found the SROC difficult to interpret and skippedit when no key was available (GP3, PM3). When a de-
tailed legend was provided and the associated text
contained accessible interpretation even participants un-
familiar with the SROC plot managed to interpret it rea-
sonably well (PM1, SR1, HE1, GP1).
Difficulties related to layout and presentation
Layout and presentation played an important role in en-
abling or hindering participants’ understanding of the
reviews. The most important presentation weaknesses
that had direct impact on participants’ understanding
were as follows:
 Figures had no key, which made them difficult to
interpret;
 Important information was not made prominent
enough (through highlighting or bulleting) and, as a
result, was easy to omit;
 There was a mismatch in the data provided in
different parts of the review, such as disagreement
in the values provided in the abstract, the results
section and the summary of results table, which led
to confusion especially in participants who were less
confident in their understanding of the review;
 The reviews contained no glossary and participants
could not check the definitions of unfamiliar terms.
Other issues had less direct impact on participants’
understanding but affected their motivation to engage
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read. In general, poorly-presented and difficult to under-
stand information was often skipped and, in some cases,
the following sections were also skipped as a result of
this. Here are some of the identified problems:
 Figures and tables were cluttered and difficult to
read;
 Tables had no orphan control and were difficult to
follow;
 Figures and associated text were disconnected and,
in some cases, the text did not relate to the figure
on the same page;
 The table of contents was not detailed enough to
guide participants unfamiliar with the structure of
review reports.
Final messages and overall understanding
After reading the review, participants were asked to re-
port - as if to a policy-making committee - the points
they considered most important. Those of them who
had little experience with systematic reviews and poor
understanding of test accuracy concepts, found the re-
views largely inaccessible, skipped large parts of the re-
port and based their final messages almost entirely on
the authors’ conclusions (GP1, GP2, R1, SR3, HE3, SR4).
Their messages often contained errors, such as misun-
derstanding the roles of the tests; misinterpreting sensi-
tivity and specificity estimates and their implications for
practice; ignoring the statistical uncertainty in the results
and poor understanding of the limitations of the review.
Within this category of participants, clinicians with little
knowledge of research methods (GP1, GP2, R1) tended
to ignore the caveats and complexities and ‘translate’ the
results into less ambiguous statements from which clear
implications for practice could be formulated. Also, the
boundary between their own preconceptions and experi-
ences with the topic and the results from the review was
often blurred, leading to conclusions unsupported by the
review results.
For instance, the conclusions section in the abstract of
the Physical examination review read:
‘When used in isolation, current evidence indicates
poor diagnostic performance of most physical tests
used to identify lumbar disc herniation. However,
most findings arise from surgical populations and may
not apply to primary care or non-selected
populations. Better performance may be obtained
when tests are combined’. (van der Windt et al.
2010, p2)
One of the clinicians reading this review concluded in
his final message the following:‘And the conclusions it comes to I would entirely
agree with, which is that it looks likely that the
combination of different techniques in examination,
whether that be straight leg raising or crossed straight
leg raising or whatever, would result in better
diagnostic accuracy and hence a more accurate
referral. So the patient gets a better service if we are
teaching people, or ensuring that people do a
combination of examination techniques.’ (GP1)
This participant skipped most of the methods, results
and discussion sections, either because he considered
them irrelevant to him as a clinician or because he
found them difficult to understand. As a result, he
missed the fact that there was not much evidence to
support the statement that better performance could be
achieved by combining different tests and no clarity as
to which tests should be combined and how to aggregate
their results. Although this was reflected in the condi-
tional form of the sentence in the authors’ conclusions
(see quotation above), he not only ignored the uncer-
tainty but also jumped to the conclusion that combining
tests will lead to better practice, a claim made nowhere
in the review.
Participants familiar with systematic review methods
tried to conduct a critical appraisal of the review and to
compare their own conclusions with those of the review
authors. Their capacity to do so depended, however, on
their knowledge of and experience with DTARs. For
some of them (PM1, SR1, HE1, PH1, SR4, SR6) specific
aspects of the review, such as the methodological quality
of the included studies and the SROC plot, remained dif-
ficult to understand. As a result they tended to focus on
familiar aspects and their final messages contained some
of the errors discussed above. On the other hand, partic-
ipants familiar with the methodology of DTAR (H1, H2,
SR2, GP3, PH2, PM2, HE2, SR5, PM4) compared, in
their final messages, their own conclusions with those of
the review authors and, in some cases, pointed out that
they would not have come to the same conclusions,
based on the data presented in the report. Some of them
(SR5, SR6, PM4) found the conclusions in the abstract
to be more cautious and consistent with the review re-
sults than the conclusions in the main body of the re-
view which, in their view, contained statements not
supported by the presented evidence (MRI versus CT re-
view). The clinicians in this group (H1, PH2, GP3) -who
read the reviews very carefully - also discussed the re-
sults with regards to their implications for clinical prac-
tice. They were, however, more cautious in their
messages and emphasised the limitations of the results
both in terms of their internal and external validity.
Only those participants who read the Galactomannan
review produced messages in which the accuracy of the
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numerical terms:
‘Err … so I didn’t get sucked into not being able to
understand those ROC curves, I’d probably be looking
for some textual information around there and I would
be … quoting verbatim … err … where people have said
at (cut off) 0.5 you miss out two (patients) but treat 17
extra, if you use (cut off) 1.5 you miss out three
(patients) but only treat five unnecessarily.’ (PM1)
As the above excerpt shows, this presentation format
allowed participants not only to understand what exactly
specific test accuracy results meant but also to commu-
nicate this information to other people, a difficulty often
mentioned by the participants.
Discussion
The application of the Cochrane review methodology to
test accuracy studies allows for a comprehensive, sys-
tematic and rigorous evaluation of the existing evidence
and, in cases where the pooling of individual studies is
appropriate, enables the calculation of more precise test
accuracy estimates. Such reviews have the potential to
play an important role in healthcare decision making by
providing clinicians and policy makers with reliable and
up-to-date information about the accuracy of diagnostic
tests. Their impact, however, may be limited if health-
care professionals find the review reports - the main
way of communicating the results - inaccessible. By
employing the think-aloud method and using the first
three DTARs published in the Cochrane library as inter-
view material, we explored how clinicians and policy
makers with different levels of background knowledge
made sense of such reports.
The results from the study demonstrate that readers
unfamiliar with this type of review may experience a
range of difficulties which, in some cases, may lead to
complete misunderstanding of the results. Some of the
identified difficulties - such as those related to poor un-
derstanding of test accuracy measures - have been well-
documented in previous studies [8,11,12,17,18,20,22,26].
Others relate to the architecture of test accuracy re-
search and the methods specific to DTARs and, as far as
we know, have not been previously reported. Although
the lack of background knowledge was the main factor
in hindering participants’ understanding, the reading
strategies they adopted and the way in which informa-
tion was presented in the reports significantly contrib-
uted to the experienced difficulties.
The interviews showed that in their current form the
reviews are written on the assumption that they would
be read by readers who have good understanding of
DTAR methods and do not require special adaptation ofthe report. Adding ‘accessibility’ features, such as defini-
tions of key terminology, detailed legends to diagrams
and text boxes offering accessible interpretations, is left
to the discretion of the review authors and, as a result,
the accessibility of the three reviews used in the studies
varied significantly. It is very likely, however, that the
majority of healthcare professionals to whom the results
from such reviews might be relevant would not be famil-
iar with DTARs and would find them difficult to under-
stand if the reports were not written with such an
audience in mind. If the Cochrane collaboration is ser-
ious in its intention to make these reports accessible to a
wider readership, then this needs to be reflected in the
editorial process which, at present, seems to be
concerned mainly with the content of the reviews. This
applies not only to the accessibility of the reviews but
also to their general readability. While reading the re-
views, participants identified a number of issues with the
layout and presentation of information that made the re-
ports difficult to read and, in some cases, led to confu-
sion and misinterpretations. Since this affected all
participants, regardless of their level of knowledge, it
makes it even more important that in the process of pre-
paring the reviews for publication, special attention is
paid to their readability, which is not the same as com-
plying with the standard Cochrane format.
Participants’ reports suggest that in the real world,
many of them, especially clinicians with little interest in
the methodology of the reviews, will read only the ab-
stract. Given the fact that such reading strategy often
resulted in misinterpretations, it is particularly important
to make the abstracts as explicit and accessible as pos-
sible, taking into account the potential misinterpreta-
tions discussed in the previous section. The following
features might be helpful:
 Presenting the results in more accessible formats,
such as frequencies, rather than percentages and
false positive and false negative rates rather than just
sensitivity and specificity;
 Explicitly defining the roles of the different tests in
the review, such as ‘index test’ and ‘reference
standard’. This would prompt participants uncertain
in their understanding of diagnostic accuracy
terminology to look up the respective definitions.
 Careful wording of the conclusions so that readers
with limited research experience understand what
exactly can be concluded from the results.
 Emphasis on the limitations of the results in terms
of validity, reliability and applicability.
Since test accuracy is only one element in the larger
puzzle of healthcare decision making, it would be naïve to
expect that improving the accessibility of the Cochrane
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decisions. A number of clinicians - with different levels of
background knowledge - commented that changes to their
practice are most likely to happen as a result of policy de-
cisions resulting in new guidelines rather than from them
reading a Cochrane review and deciding that changes are
needed. On the other hand, policy decisions are often the
final stage of a long process that starts with new evidence
changing the perceptions of different groups of stake-
holders and leading to actions that eventually will result in
changes of the current practice. In this respect, the
Cochrane DTARs has a special role to play - if they are ac-
cessible to a wider audience they are more likely to
catalyze the process of change and to contribute to the
prompt update of the current practices.
Limitations of the study
Given the small and highly diverse sample of the study,
the results should be treated with caution and should not
be used to make generalizations about the level of under-
standing of different professional groups. Rather, they
should be used to warn authors and editors of Cochrane
DTARs about some of the potential difficulties that
healthcare professionals and policy makers may encounter
when reading such a review and to encourage a debate
about the best ways of communicating the results from
the Cochrane DTARs to different audiences. Nevertheless,
the fact that the sample consisted of more motivated and
experienced healthcare professionals suggests that the re-
sults might represent the best case scenario and that in
the general population of healthcare professionals these
difficulties might be much more pronounced.
Undoubtedly, participants’ behaviour was influenced
by the setup of the interview and, therefore, the way in
which participants read the reviews may not be repre-
sentative of their ‘real life’ behavior. For example some
participants from the ‘expert’ end of the spectrum
commented that in ‘real life’ they would take much lon-
ger time to read the review, especially if they were to re-
port to a policy making committee, and that they would
read some of the sections they skipped during the inter-
view. Most of the participants in the interview sample,
however, stated that they would not read a systematic re-
view for longer than one hour, which agrees with the re-
sults from our online survey, in which over 80% of the
sample (n = 103) stated the same and 50% stated that
they would not read a systematic review for longer than
half an hour (see Additional file 1). We can also specu-
late that the interview situation may have had the oppos-
ite effect on participants, encouraging them to make an
extra effort and to be more diligent in their reading.
Many of them commented that in ‘real life’ they would
read only the abstract, especially if they felt that the re-
sults were inconclusive or unreliable.Most of the analysis was conducted by the first author
and some subjective interpretation may also be present.
A portion of the interviews, however, were also watched
by the second author, and the results were frequently
discussed in the team, to make sure that their interpret-
ation was correct. We also presented some of the in-
terim results to the members of the steering group and
received feedback on our interpretations.Conclusions
Our results clearly demonstrate that participants who
have no previous experience with DTARs may find this
type of review challenging and may encounter a range of
difficulties leading, in some cases, to complete misun-
derstanding of the results. These difficulties stem from
the interaction between participants’ background know-
ledge, the reading strategies they employ and the way in
which information is presented in the reports. In their
present format the Cochrane DTARs are written more
for specialists than for readers with basic understanding
of DTAR concepts and methods. Making the reviews
more accessible by adding a glossary, detailed keys to di-
agrams, plain language summary boxes and other ‘acces-
sibility’ features is likely to help readers who are not
specialists in diagnostic research to make better use of
the reviews. However, this will require changes to the
process of preparing Cochrane DTARs for publication,
with consideration being given not only to the contents
of the reviews but also to their readability and accessibil-
ity. Since many healthcare professionals may not read
the whole report, special care should be taken to make
the abstract as explicit and accessible as possible so that
even readers not familiar with this type of review under-
stand correctly the main results and their implications.Additional file
Additional file 1: Results from the online survey.Abbreviations
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